AWARD
65 -- Production of Therapeutic (casirivimab and imdevimab) in Support of National Emergency Response to Coronavirus 2019 (COVID-19)
- Notice Date
- 1/13/2021 10:02:22 AM
- Notice Type
- Award Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- W6QK ACC-PICA PICATINNY ARSENAL NJ 07806-5000 USA
- ZIP Code
- 07806-5000
- Solicitation Number
- W15QKN-21-C-0014
- Archive Date
- 01/29/2021
- Award Number
- W15QKN-21-C-0014
- Award Date
- 01/12/2021
- Awardee
- REGENERON PHARMACEUTICALS, INC. Tarrytown NY USA
- Award Amount
- 2625000000.00
- Description
- Production of Regeneron Therapeutic (casirivimab and imdevimab) in Support of National Emergency Response to Coronavirus 2019 (COVID-19). This is a sole source action under the authority of 10 United States Code (U.S.C.) 2304(c)(2), as implemented by Federal Acquisition Regulation (FAR) 6.302-2 -- Unusual and Compelling Urgency.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/1302b19b8ed549b9b9eda48d8b01554a/view)
- Record
- SN05890825-F 20210115/210113230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |